What is the global market size of In-Vitro Diagnostics Market?

The global in-vitro diagnostics market size was valued at USD 83.50 Billion in 2022 and is poised to grow from USD 87.93 Billion in 2023 to USD 132.90 Billion by 2031, growing at a CAGR of 5.3% during the forecast period (2024-2031).

Who are the key vendors in the Global In-Vitro Diagnostics Market?

Investing in the research and development of advanced in-vitro diagnostics solutions will be a top priority for all market players. Increasing affordability of in-vitro diagnostics tests should also be a key focus for in-vitro diagnostics providers. Launching new in-vitro diagnostics products and tests will help companies stay competitive and stand out in the global market. Providing favorable reimbursement for in-vitro diagnostics will also be a crucial aspect for business expandion in the long run. 'Roche Diagnostics (Switzerland) ', 'Danaher Corporation (U.S.) ', 'Abbott Laboratories (U.S.) ', 'Becton, Dickinson and Company (U.S.) ', 'Bio-Rad Laboratories, Inc. (U.S.) ', 'QIAGEN N.V. (Netherlands) ', 'Quidel Corporation (U.S.) ', 'Siemens Healthineers (Germany) ', 'Sysmex Corporation (Japan) ', 'Thermo Fisher Scientific, Inc (U.S.) ', 'bioMérieux SA (France) ', 'Agilent Technologies, Inc. (U.S.) ', 'DiaSorin S.p.A (Italy) ', 'Illumina, Inc. (U.S.) ', 'Hologic, Inc. (U.S.) ', 'Devyser PerkinElmer Inc. (U.S.) ', 'Chembio Diagnostics, Inc. (U.S.) ', 'Surmodics, Inc. (U.S.) ', 'Menarini Silicon Biosystems (Italy) ', 'SpeeDx Pty. Ltd. (Australia) '

What is the key driver of Global In-Vitro Diagnostics Market?

Aging people are more susceptible to different kinds of diseases and require regular testing to keep them healthy. This is why as aging population increases around the world, it is also expected to boost the demand for in-vitro diagnostics and other types of diagnostics products in the future.

In-Vitro Diagnostics Market Regional Analysis

Skyquest Technology's expert advisors have carried out comprehensive global market analysis on the in-vitro diagnostics market, covering regional industry trends and market insights. Our team of analysts have conducted in-depth primary and secondary research to provide regional industry analysis and forecast of in-vitro diagnostics market across North America, South America, Europe, Asia, the Middle East, and Africa.

In-Vitro Diagnostics Market Regional Insights

The presence of developed healthcare infrastructure and key diagnostics providers allows North America to hold a dominant market share. Growing investments in R&D of novel diagnostics and the rising popularity of homecare in this region are also expected to boost sales of in-vitro diagnostics products in the future. Favorable regulatory environment and rising adoption of advanced diagnostics technologies are making the United States a key market for in-vitro diagnostics companies operating in North America.

Growing investments in healthcare infrastructure development and rising demand for advanced diagnostic solutions are helping Asia Pacific become the most opportune market in the world. China, Japan, and India are slated to be the most lucrative markets for in-vitro diagnostics companies in this region owing to growing senescent population and high prevalence of chronic diseases. Rising awareness regarding the benefits of in-vitro diagnostics in this region will also create new business opportunities going forward.

In-Vitro Diagnostics Market Report Snapshots

REPORT OVERVIEW BUY NOW

REQUEST FOR SAMPLE

Want to customize this report?

REQUEST FREE CUSTOMIZATION

FAQs

In-Vitro Diagnostics Market size was valued at USD 87.93 Billion in 2023 and is poised to grow from USD 92.59 Billion in 2024 to USD 139.94 Billion by 2032, growing at a CAGR of 5.3% during the forecast period (2025-2032).

Investing in the research and development of advanced in-vitro diagnostics solutions will be a top priority for all market players. Increasing affordability of in-vitro diagnostics tests should also be a key focus for in-vitro diagnostics providers. Launching new in-vitro diagnostics products and tests will help companies stay competitive and stand out in the global market. Providing favorable reimbursement for in-vitro diagnostics will also be a crucial aspect for business expandion in the long run. 'Roche ', 'Siemens Healthineers ', 'Thermo Fisher Scientific ', 'Abbott Laboratories ', 'bioMérieux ', 'Bio-Rad Laboratories ', 'QIAGEN ', 'Agilent Technologies ', 'Sysmex Corporation ', 'Fujifilm Holdings ', 'Illumina ', 'Shimadzu Corporation ', 'DiaSorin ', 'Grifols ', 'Quest Diagnostics ', 'Transasia Bio-Medicals ', 'Tulip Diagnostics ', 'NeoDx ', 'Voxtur Bio ', 'Peerless Biotech '

The prospect of home care is becoming more attractive and common worldwide. In-vitro diagnostics companies can focus on the development of test kits that can be used at home easily without medical supervision to maximize their revenue generation and capitalize on the growing popularity of homecare around the world.

Feedback From Our Clients

"We have purchased recently a report from SkyQuest Technology, and we are happy to inform you that this report was so useful and practical for our team. Skyquest Team was very active and our queries were followed up completely.It was amazing. "

- Mr. Ali Zali, Commercial Director, ICIIC Iran.

In-Vitro Diagnostics Market Regional Analysis

In-Vitro Diagnostics Market Regional Insights

In-Vitro Diagnostics Market Report Snapshots

FAQs

What is the global market size of In-Vitro Diagnostics Market?

Who are the key vendors in the In-Vitro Diagnostics Market?

What is the key driver of In-Vitro Diagnostics Market?

What is the key market trend for In-Vitro Diagnostics Market?

Which region accounted for the largest share in In-Vitro Diagnostics Market?

Request Free Customization